Clinical Trials for Devang Pastakia

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
PreventionVICCPED12112
01/04/2013
NMTRC003: A Phase II Preventative Trial of DFMO (eflornithine HCI) as a Single Agent in Patients with High Risk Neuroblastoma in Remission

Back to Find By Doctor

You do not have JavaScript enabled. This site works better with JavaScript turned on.